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1. Introduction     
Translational research is a growing field of science that seeks to discover the molecular 
underpinnings of diseases and treatment outcomes in any individual patient (Horig, 
Marincola et al. 2005). The mission has driven researchers out of isolated and discipline-
oriented studies into collaborative and trans-disciplinary research efforts known as team 
science (Guimerà, Uzzi et al. 2005). In this new scientific arena, the ability to search for an 
individual’s biomedical data across various domains and sources via a common 
computational platform is a vital component for the formulation of sophisticated hypotheses 
and research decisions.  
Biomedical data is composed of records from both clinical practice and basic research. Each 
sector has distinct data governance policies and database management rules. While basic 
biological research data sources are open— some 1,230 curated databases are available in 
the public domain and accessible through the Internet (Cochrane and Galperin 2010), all 
primary clinical data sources are kept private with rigorous data access controls, due to 
Health Insurance Portability and Accountability Act (HIPAA) regulations (Faddick 1997). 
Furthermore, while basic biological research data sources frequently make data elements, 
database schemas, metadata information and application programming interface (API) 
available to the public, the majority of clinical data sources are hosted by proprietary 
commercial software. The vendors (or developers) of these tools usually disclose little 
information about schema and metadata to third-parties. Finally, while most basic research 
(e.g., biological molecule or pathway) data sources must have data integrity at the species 
level, translational research requires data integrity at the individual patient level. Indeed, 
integrated and individualized biomedical data sources will need to make a significant 
contribution to translational research in order to truly achieve personalized medicine. 
However, generating such data sources  is a more difficult task than the already challenging 
mission of integrating basic biological research data (Stein 2008).  
Data integration is the process of combining data from different sources into a unified 
format with consistent description and logical organization. After more than two decades of 
research, the topic continues to become more challenging due to increasing demands and 
persistent obstacles (Batini, Lenzerini et al. 1986; Bernstein and Haas 2008; Agrawal, 
Ailamaki et al. 2009). In this chapter, we focus on the issues that must be addressed to fulfil 
the demands for individualized biomedical data integration and introduce a customized 
warehousing approach for this particular purpose. 
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2.1 Current status of biomedical data 
To illustrate the demand of integrating individualized biomedical data, we start with an 
example: for a cancer translational researcher to assess the association between the genetic 
background and the occurrence of a particular cancer and its treatment outcomes, she likely 
needs to:   
1) screen family history through medical surveys on a selected cohort; 2) read pathology 
report about each individual’s histological diagnosis; 3) check surgical, chemo, and radiation 
records in the clinics; 4) follow the outcomes and adverse events of the treatments; 5) record 
dates and evidences of the cancer recurrence and metastasis; 6) find DNA samples from 
specimen bank; and 7) conduct genotyping experiments and link the genotype results back 
to the phonotypical records.    
In order to extract meaningful information from these data, the researcher needs to have 
these data distinguishably aligned to individual persons, but linking these data together, 
even in a modest number of subjects, often fails due to data heterogeneity and discontinuity. 
Combining biomedical data with integrity at individual level frequently encounters four 
distinct challenges.  
The first challenge is caused by source heterogeneity. Data elements and/or schemas for the 
same domain data that are designed by independent parties will normally be semantically 
different. Such heterogeneity may also exist in different (or the same) versions of software 
developed by the same party. To further complicate matters, many data sources are subject 
to dynamic change in all aspects, including data structures, ontology standards, and 
instance data coding methods. These sources customarily do not provide metadata or 
mapping information between datasets from previous and newer versions.  
The second challenge stems from data descriptor inconsistencies. Many biomedical domains 
do not have established ontologies and others have more than one set of standard 
taxonomies. For example, one can find official taxonomies for describing cancers in 
SNOMED (Cote and Robboy 1980), International Classification of Disease (ICD) (Cimino 1996), 
and the NCI-thesaurus (Sioutos, de Coronado et al. 2007).  
The third challenge comes from data source management styles. Most data sources are 
isolated and autonomously operated. These sources typically neither map nor retain the 
primary identifiers (of a person or the specimens that originated from the person) created in 
the other sources. The silo settings of the data sources not only generate segregated datasets 
but often require repetitive re-entry of the same records (e.g., patient demographic data) by 
hand into different sources. This practice increases the risk of human error.  
The fourth challenge is due to low data source interoperability. The majority of clinical data 
sources are neither programmatically accessible (syntactic interoperability) nor have 
metadata available for the source data (semantic interoperability).  
Many of these problems have been continual to date and will linger for the foreseeable 
future. As a consequence, biomedical source data are typically heterogeneous, inconsistent, 
fragmented, dirty and difficult to process. Valuable information embedded within the data 
cannot be consumed until the data are cleansed, unified, standardized, and integrated.  
2.2 Related data integration regimes 
The purpose of data integration is to deliver integrated information. This purpose can be 
realized via either permanent (physical) or transient (view) data integration. Among the 
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various information integration approaches, data warehousing, view integration, and 
information mashup are popular regimes that are actively discussed in IT and informatics 
publications (Halevy 2001; Jhingran 2006; Goble and Stevens 2008). Each regime has its own 
distinct design principle and system architecture.  
2.2.1 Data warehousing
 
While describing the architecture of a data warehousing solution, many focus on a 
multidimensional database (Louie, Mork et al. 2007; Goble and Stevens 2008). This database-
centred approach is widely used across multiple fields and has a well-documented history 
in regards to its evolution. A warehouse delivers integrated information by organizing and 
storing data from various sources within a physical schema so that the integrated data can 
be reused for a variety of applications. Since the basic requirement for a database to function 
is data availability, the warehousing approach appears to be more tolerant to various data 
source conditions than its counterpart solutions which all require data sources to be 
interoperable and accessible. Warehousing is generally considered most suitable for 
historical data accumulation, quality data integration, and post-integration data curation 
and annotation (Halevy, Ashish et al. 2005). In biomedical informatics, the warehousing 
approach is considered most suitable for personalized biomedical data integration (Louie, 
Mork et al. 2007; Wang, Liu et al. 2009).  
The major drawbacks of the warehousing approach are its association with stale data and 
the resource-consuming nature of system maintenance. These negative aspects reveal a 
simple truth about warehousing: data supply issues are the biggest obstacle and financial 
drain to the ultimate success of the strategy. These issues demonstrate the need for a data 
extraction-transformation-loading (ETL) process that determines the quality and freshness of 
integrated data. Thus, we discuss in greater depth of both the database and the ETL process.  
2.2.1.1 Multidimensional database modelling 
The database in a warehousing strategy must store multidimensional data. Three distinct 
conceptual modelling methods are often employed for database design: 1) the Entity-
Relationship (ER) model (Chen 1976; Kamble 2008); 2) Entity-Attribute-Value representation 
with classes and relationships (EAV/CR) model (Dinu and Nadkarni 2007; Lowe, Ferris et 
al. 2009); and 3) Object-Oriented Database (OODB) (Trujillo, Palomar et al. 2001). Although 
no consensus has been reached concerning modelling standards, we prefer the ER model 
due to its solid mathematic foundation, data structure semantic clarity, and data 
presentation transparency. These features not only benefit high-throughput data 
deployment at the database layer for integration but also support satisfactory query 
performance at the user-application interface. In addition, since the ER model requires 
semantic clarity and consistency for each attribute element during cross-source data 
processing, the delivery of useful data and consumable information is better ensured.  
At the implementation level, a data warehouse is suggested to have a star schema (a single 
large fact table and many smaller dimension tables) to improve application performance by 
reducing the time required to join multiple tables to answer a query (Kimball, Reeves et al. 
1998). However, a highly de-normalized schema, like a star schema, also increases cost of 
database maintenance. With materialized-view technology being well-developed, the de-
normalization of data entities at the primary schema level is no longer critical. Materialized-
view technology is capable of flexibly aggregating data into any combination.  
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2.2.1.2 ETL modelling and tools 
A warehouse relies on an ETL process to refill and refresh data from heterogeneous sources 
into a predefined schema for data integration. The history of developing and optimizing 
ETL is directly tied to the history of data warehouse systems. Yet, a significant technological 
breakthrough for ETL remains to be seen. In general, the process remains error-prone and 
labour-intensive (Rizzi, Abello et al. 2006). The methods related to the different stages of an  
ETL process can be briefly categorized into the following: 1) schema mapping (Bernstein 
and Rahm 2001); 2) metadata collection and management (Kolaitis 2005); 3) error detection 
and data cleansing (Kalashnikov and Mehrotra 2006); and 4) systematic modelling of the 
entire ETL process (Vassiliadis, Simitsis et al. 2002).  
The pressing demand for data integration has spurred the development of commercial ETL 
software packages. Examples include DataStage (Oracle), Informix (IBM), and products 
from smaller vendors. To date, all ETL strategies still involve human intervention, albeit at 
different levels. Many approaches appear to be exhaustive and obsessive in the hierarchical 
levels of schema mapping while paying insufficient attention to data value integration. 
Some are inherently brittle, often without a clear measure of success for an ETL workflow in 
the real world. In the field of biomedical informatics, which fiercely promotes interoperable 
data integration (Komatsoulis, Warzel et al. 2008), ETL remains an autonomous in-house 
activity and formal reports on the topic are seldom seen.  
2.2.2 View integration 
The architecture behind view integration consists of an interoperable data grid with 
constituent primary databases that are autonomous, disparate, and heterogeneous. Yet, data 
from these databases need to be aligned to a common virtual schema during integration 
(Halevy 2001; Stein 2002). In this regime, queries issued by users are posed to the virtual 
schema and then translated into various customized queries against disparate data sources. 
Extracted source data is then transformed on the fly to meet the definitions of the common 
schema. Finally, unified data is presented to users as integrated information.  
Because view integration combines data dynamically, without any persistent physical data 
aggregation, it can provide real time information. However, its effectiveness depends 
critically on the interoperability and network accessibility of every data source of interest, 
which (at least at the current time) seems unlikely to occur in practice.  In addition, because 
view integration requires the entire data aggregation process from disparate sources to the 
view to be fully automated, it provides less control of data quality than data warehousing 
approaches in which manual curation steps can be included in the ETL process. This lack of 
sufficient data quality control is a serious concern for biomedical informatics researchers 
(Goble, Stevens et al. 2008; Galperin and Cochrane 2009).  
To date, view integration systems with production level maturity are not commonly seen in 
the real world. However, the design concepts utilized in view integration, including global-
as-view (GAV) and local-as-view (LAV), are valuable principles to all data integration 
efforts (Lenzerini 2002). In GAV, the virtual schema is made adjustable to accommodate all 
source data elements. In LAV, each source data is individually managed to be transformed 
to align to this global view.  
2.2.3 Information mashup 
The architecture behind the information mashup approach comprises of an open fabric which 
augments information from different sources that allow their API accessible through the 
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Internet. Although having some similarities to ETL, mashup is advantageous both in its ability 
to be light-weight and its utilization of a service model that is easily extensible via Web 2.0 
techniques, e.g., representational state transfer (REST) technology (Fielding and Taylor 2002). The 
prerequisite for a mashup fabric to consistently present (overlay) different messages on a web 
interface is standardized information formats in the atomic data elements that carry instance 
data. These data feeds are either staged within the sources (or at a middleware) or converted to 
have consistent data interpretation, e.g., geographic code, and formats on the fly. For example, 
a (subject-predicate-object) triplet expressed in the W3C-standard resource description framework 
(RDF) carries metadata information for related atomic data elements. Therefore, RDF can be 
easily converted into an ER model and vice versa.  
Unlike view integration, which has a predefined schema, a mashup fabric uses structured 
basic data elements to form information presentations that are not rigorously structured, 
e.g., information situational display overlay (Jhingran 2006). Therefore, a mashup strategy 
becomes more implementable and as a result, has been used in many information 
integration-lite tasks (Franklin, Halevy et al. 2005; Goble and Stevens 2008). Examples 
include Google maps (Wong and Hong 2007) and Avian Flu maps (Butler 2006).  
However, the openness of the mashup fabric along with its integration lite nature limits its 
application as the first layer technology option for personalized biomedical data integration. 
At this layer, the integration framework must manipulate primary source data in a secluded 
network because the data contain protected health information (PHI). Furthermore, data 
integration with individualized integrity from longitudinal records is an integration-heavy 
task, which is better handled by a relational database in a secure environment alleviating 
HIPAA concerns. However, the mashup strategy may still be suitable for higher-level 
(anonymous) biomedical data integration for population studies that require evidence from 
a significant number of individuals in a particular domain or against a geographic 
background.  
2.3 Related human-intensive efforts 
In addition to computationally heavy informatics solutions, human-developed information 
research is also a crucial component in overall information delivery (Bernstam, Smith et al. 
2010). These efforts include domain ontology creation (Yu 2006) and mapping for multiple 
standards in the same domain, e.g., unified medical language system (UMLS) (Bodenreider 
2004) for SNOMED and ICD. However, despite the challenge of mapping between existing 
standards, newer standards keep emerging. Mapping concepts between different ontologies 
in the same domain or different versions within the same ontology requires good mapping 
references, which are usually either inadequate or not computable, e.g., cancer registry 
coding schema (Edge, Byrd et al. 2010). Nevertheless, discussions concerning how to best 
use human effort in the field of informatics are rare. It is evident that these efforts can either 
benefit or hinder data integration efficiency. 
3. Methods 
3.1 Conceptual design of the warehousing framework  
Based on our analysis of existing data integration regimes, biomedical data statuses, and 
conditions of data sources in the real world, we adopted a warehousing strategy to address 
the general need for personalized data integration. The purpose of our approach is to 
provide a computation framework aimed at data unification for integration (UNIFIN). By 
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design, the UNIFIN framework contains two essential technical components: a 
multidimensional database, the Translational Data Mart (TraM), and a customized ETL 
process, the Data Translation Workflow (TraW). UNIFIN also includes an interoperable 
information integration mechanism, empowered by REST and SOA technologies for data 
that do not need manipulation during the integration process. Examples of such data 
include homogeneous molecular sequence records and binary image datasets.  
In this chapter, we focus on describing the semi-automated ETL workflow for 
heterogeneous text data processing. We explain data processing, integration and ontology 
issues collectively, with the intent of drawing a systematic picture describing a warehousing 
regime that is customized for personalized data integration. Although TraM and TraW have 
been developed by the same team, each is designed to be independently portable, meaning 
that TraM can readily accept data from other ETL tools and TraW, after customization, can 
supply data to target databases other than TraM.  
3.2 Data warehouse TraM  
3.2.1 Domain ontology integrated ER conceptual model 
We used the top-down design method to model the TraM database. The modelling is based 
on our analysis of real world biomedical data. The results of the analysis are depicted in a 
four-dimensional data space (Fig 1A). The first dimension comprises study objects, which 
can range from human individuals to biomaterials derived from a human body. 
Restrictively mapping these objects according to their origins (unique persons) is essential to 













Fig. 1. Data warehouse modelling: A) Biomedical data anatomy; B) DO-ER conceptual 
model for the TraM database. The square shapes in panel B indicate data entities and the 
diamond shapes indicate relationships between the entities. The orange colour indicates that 
the entity can be either a regular dictionary lookup table or a leaf class entity in a domain 
ontology.  
The second dimension is positioned with a variety of domain concepts that are present in an 
extensive biomedical practice and research field. Domain concepts can either be classified in 
domain ontologies or remain unclassified until classification takes place during integration. 
There are no direct logical connections between the different domain ontologies in an 
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evidence-based data source. The associations among domain concepts will be established 
when they are applied to study objects that are derived from the same individual.  
The other two dimensions concern the times and geographic locations at which research or 
clinical actions take place, respectively. These data points are consistent variables associated 
with all instance (fact) data and are useful to track instances longitudinally and 
geographically. This analysis is the foundation for TraM database modelling. 
We then create a unique domain-ontology integrated entity-relationship (DO-ER) model to 
interpret the data anatomy delineated in Fig 1A with the following consistency. (See Fig 1B 
for a highly simplified DO-ER model.) 
1. The instance data generated between DO and study objects are arranged in a many-to-
many relationship.  
2. Domain concept descriptors are treated as data rather than data elements. Descriptors 
are either adopted from well-established public ontology data sources or created by 
domain experts with an ontology data structure provided by TraM, assuming that there 
is no reputable ontology existing within that domain. Thus, domain concepts are either 
organized as simply as a single entity for well-defined taxonomies or as complex as a 
set of entities for classification of concepts in a particular domain.  
3. Study objects (a person or biomaterials derived from the person) are forced to be linked 
to each other according to their origins regardless of the primary data sources from 
which they come.  
There are three fuzzy areas that need to be clarified for the DO-ER model. The first is the 
difference between an integrated DO in the DO-ER model versus a free-standing DO for 
sophisticated DO development. The DO development in the DO-ER model needs to be 
balanced between its integrity in concept classification (meaning the same concept should 
not be described by different words and vice versa) and its historical association with the 
instance data (meaning some DO terms might have been used to describe instance data). 
The data values between the DO and ER need to be maintained regularly to align the 
instance data descriptors to the improved DO terms. For this purpose, we suggest that 
concept classification be rigorously normalized, meaning to make concept of an attribute not 
divisible in the leaf class of the DO, because merging data with unified descriptor is always 
easier than splitting data into two or more different data fields. The advantage of the DO-ER 
model is that these changes and alignments usually do not affect the database schema. The 
latter remains stable so there is no need to modify application programs.  
The second is the conceptual design underlying the DO structures in the DO-ER model. In 
fact, the DO under this context is also modelled by ER technique, which is conceptually 
distinct from the popularly adopted EAV modelling technique in the biomedical informatics 
field (Lowe, Ferris et al. 2009) . The major difference is that the ER underlying the DO has 
normalized semantics for each attribute, while the EAV does not.  
The third is determining the appropriate extent of DO development that should go into an 
evidence-based database. We believe that TraM users in general have neither the intention 
nor the resources to make TraM a DO producer. Thus, our purpose in allowing for DO 
development within TraM is solely to satisfy the minimal requirement of harmonizing 
highly heterogeneous data with controlled vocabulary, so that the DO is developed as 
needed. The resulting standardization of data concept abstractions, classifications, and 
descriptions will make it easier to merge data with future reputable DO standards as they 
(hopefully) emerge. Under this context, we further explain a use case underlined with DO-
ER transformation-integration mechanism in section 4.2, and detail how an evolving DO 
may affect data integration workflow in section 3.3.4. 
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3.2.2 Enforcing personalized data integrity  
Personalized data integrity is enforced throughout the entire TraM schema. To achieve this 
level of quality control, the first required condition is to identify uniqueness of a person in the 
system. HIPAA regulations categorize a person’s demographic information and medical 
administrative identifiers and dates as PHI that should not be disclosed to researchers or 
transferred between databases without rigorous legal protections. However, as a person is 
mobile, an individual’s medical records are often entered into multiple databases in more than 
one medical institution or clinic. Without PHI, it is almost impossible to reliably identify the 
uniqueness of a person unless 1) the person’s identifiers are mapped across all data sources or 
2) there is a universal identifier used in all healthcare and research domains. Neither condition 
currently exists. Therefore, a data warehouse often must be HIPAA-compliant to contain PHI 
data to verify the uniqueness of a person. This is the case in the TraM operation. Once the 
uniqueness of a person is identified, TraM has a built-in mechanism that automatically unlinks 
the PHI records to form the materialized view. Since the materialized view is the schema that 
answers queries, the application program can only access de-identified data, and therefore, 
regular users do not see PHI but can still receive reliable individualized information.  
3.3 ETL process TraW 
The TraM data model reflects one particular interpretation (our interpretation) of 
biomedical data in the real world. Independent parties always have different opinions about 
how a warehouse database should be constructed. Different data sources also interpret the 
same domain data differently both among themselves and from a warehouse. To bridge 
these gaps, TraW is designed to be configurable to adapt to different sources and targets. 
Since most medical data sources do not disclose database schema or support 
interoperability, we have focused in designing TraW on gathering the basic data elements 
that carry data and performing data extraction from available electronic data forms (Free 
text is not included in this discussion.). Unlike TraM, which has a relatively free-standing 
architecture, TraW is an open fabric with four essential highly configurable components: 
1. A mechanism to collect metadata—routinely not available in source data deliveries. A 
web-based data element registration interface is required to collect metadata across all 
sources. 
2. A set of systematically designed and relatively stable domain data templates, which 
serve as a data processing workbench to replace numerous intermediate tables and 
views that are usually autonomously created by individual engineers in an 
uncontrolled ETL process.  
3. A set of tools that manipulate data structures and descriptions to transform 
heterogeneous data into an acceptable level of uniformity and consistency as required 
by the target schema. 
4. A set of dynamically evolving domain ontologies and data mapping references which 
are needed for data structure unification and descriptor standardization.  
Behind these components is a relational database schema that supports TraW and records its 
data processing history. 
3.3.1 Metadata collection 
TraW treats all data sources as new by collecting their most up-to-date metadata in each 
batch data collection through a web-based application interface. If the existing sources do 
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not have any changes since the previous update, the source data managers are required to 
sign an online confirmation sheet for the current submission. To avoid another level of 
heterogeneity as generated by metadata description, TraW provides a pre-defined metadata 
list for data providers to choose from through the registration interface. These metadata are 
defined based on the TraW domain templates (the differences between domain templates 
and target schema are detailed in section 3.3.2). These metadata will not completely cover all 
source data elements, not necessarily because they do not represent the meanings of those 
data, but because they do not share the same semantic interpretations for the same kinds of 
data. Thus, TraW allows data providers to create their own metadata for unmatched data 
fields. 
3.3.2 Domain data template 
In section 2.2.2, we described the GAV and LAV concepts. The TraW domain template is 
derived from the GAV concept. The difference is that the GAV in view integration is a virtual 
schema that responds directly to query commands, while the domain template in TraW both 
carries physical data and serves as a workbench to stage data before integration. Unlike a 
target schema, which has normalized domain entities and relationships governed by 
rigorous rules to assure data integrity, domain templates in TraW do not have entity level 
data structures, nor do they have relationship and redundancy constraints. Instead, since 
there are no concerns about the user application interface, the templates can simply be 
frequently edited in order to accommodate the new source data elements. However, these 
templates must have three essential categories of data elements.  
First, a template must contain elements that support minimal information about data integration 
(MIADI). MIADI is presented by a set of primary identifiers from different sources and is 
required for cross-domain data integration. These identifiers, which come from independent 
sources, should be capable of being mapped to each other when study objects are derived 
from the same person. If the mapping linkage is broken, PHI will be required to rebuild data 
continuity and integrity for one person may have multiple identifiers if served in different 
medical facilities.  
Second, a template must contain the domain common data element (CDE), a set of abstracted 
data concepts that can represent various disciplinary data within a domain. For example, 
cancer staging data elements are required for all types of cancers so they are the CDE for 
evidence oncology data. Elements for time stamps and geographic locations are also CDEs 
for cross-domain incidence data. Domain CDEs are usually defined through numerous 
discussions between informaticians and domain experts if there is no available CDE that is 
widely accepted in the public domain.  
Third, the template must contain elements that carry data source information, e.g., source 
database names, owner names of the databases, data versions, submission times, and etc, 
which are collectively called data provenance information. This information is required for 
data curation and tracking.  
ETL workers continue to debate what exactly constitutes domain CDE, despite significant 
efforts to seek consensus within or across biomedical domains (Cimino, Hayamizu et al. 
2009). Each ETL often has its own distinct semantic interpretation of data. Therefore, TraW 
should only provide templates with the three specified element categories in order to give 
ETL workers flexibility in configuring their own workbench.  
Generally speaking, domain templates have looser control on CDE formulation than do target 
schemas because they are intended to cover all source data elements, including those that have 
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a semantic disparity on the same domain data. For this reason, a domain template actually 
serves as a data transformation medium which in principle, has a consistent data structure as 
the target schema while simultaneously containing both an original (O-form) and a 
standardized (S-form) form for each data element. Data need to be in a semantically consistent 
structure before they can be standardized. Data in S-form are completely consistent in both 
structure and description to the target schema. Reaching semantic consistency relies on a set of 
data transformation algorithms and semantic mapping references.  
3.3.3 Data transformation algorithms 
Data transformation is a materialized process of LAV (refer to section 2.2.2), meaning that it 
converts data from each source to a common data schema with consistent semantic 
interpretations. Since we focus mainly on basic data element transformation, we mashup 
these elements from different sources and rearrange them into different domain templates. 
Because each domain template contains a data provenance element, we can trace every 
single record (per row) by its provenance tag through the entire data manipulation process. 
The transformation of a data element proceeds in two steps: data structure unification and 
then data value standardization. The algorithms behind these two steps are generic to all 
domain data but depend on two kinds of references to perform accurately. These references 
are the domain ontologies and the mapping media between sources and target schema 
(more details in 3.3.4). In this section, we mainly explain data transformation algorithms.  
In our experience with integrating data from more than 100 sources, we have found that 
about 50% of source data elements could not find semantic matches among themselves or to 
the target schema even when they carried the same domain data. Within these semantically 
unmatched data elements, we consistently found that more than 80% of the elements are 
generated through hard-coding computation, meaning that data instances are treated as 
variable carriers, or in other words, as attribute or column names (Fig 2.I). This practice 
results in data elements with extremely limited information representation and produces an 
enormous amount of semantically heterogeneous data elements. It is impossible to 
standardize the data description in such settings unless instance values are released from 
the name domains of the data elements. The algorithm to transform this kind of data 
structure is quite straightforward, unambiguous, and powerful. The process is denoted in 
the formula:  
{ } { }(1) (i) (i) (specified)f x ,  y   f x ,  y=>  
In this formula, a data table is treated as a two dimensional data matrix. x represents rows and 
y represents columns. Column names (left side of arrow) are treated as data values in the first 
row. They are transposed (repositioned) into rows under properly abstracted variable holders 
(columns). The associated data with those column names are rearranged accordingly (Fig 2.II). 
The decision as to which column names are transposed into which rows and under which 
columns is made with information provided by a set of mapping references. Since this process 
often transforms data from a wide form data matrix into a long form, we refer to it as a wide-
to-long transformation. The fundamental difference between this long form data table versus 
an EAV long form data table is that the data table in our system is composed with semantically 
normalized data elements while EAV data table is not.  
Once data values are released from data structures under properly abstracted data elements, 
normalization and standardization of the value expression can take place. This process is 
www.intechopen.com
Personalized Biomedical Data Integration 
 
675 
called data descriptor translation and relies on a mapping reference that specifies which 
specific irregular expressions or piece of vocabulary are to be replaced by standardized 
ones. At the same time, further annotation to the instance data can be performed based on 
the metadata. For example, the test values in Fig 2.II are measured from two different test 
methods for the same testing purpose. In this circumstance, unless the test methods are also 
annotated, the testing results cannot be normalized for an apple-to-apple comparison. In 
addition, the assessment (asmt) field is added to justify the score values read from different 
testing methods (Fig 2.III).  
There are other complex data structure issues besides hard-coded data elements requiring 
significant cognitional analysis to organize data. We discuss these issues in section 5. 
 










PT_ID TEST SCORE SCORE_PCT ASMT METHOD
1 C 10 Positive Panel-A
2 B 20 Negative Panel-A
2 A 10 Positive Panel-A
3 D 20 Negative Panel-B









Fig. 2. An example of data transformation: I) Hard-coded data elements; II) Semantically 
unified data structure; and III) Standardized and normalized data values with additional 
annotation based on metadata and data mapping references 
3.3.4 Domain ontology and mapping references 
Domain ontology and mapping references are human-intensive products that need to be 
designed to be computable and reusable for future data processing. In general, it is simpler 
to produce mapping references between irregular data descriptors and a well-established 
domain ontology. The problem is how to align heterogeneous source data elements and 
their data value descriptors to a domain ontology that is also under constant development. 
Our solution is to set several rules for domain ontology developers and provide a backbone 
structure to organize the domain ontology.  
1. We outline the hierarchy of a domain ontology structure with root, branch, category 
and leaf classes, and allow category classes to be further divided into sub-categories.  
2. We pre-define attributes for the leaf class, so that the leaf class property will be 
organized into a set of common data elements for this particular ontology. 
3. Although domain concept descriptors are treated as data values in ontology, they 
should be in unique expressions as each should represent a unique concept.  
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We train domain experts with these rules before they develop ontologies, as improper 
classification is difficult to detect automatically. We maintain data mapping references in a 
key-value table, with the standardized taxonomy as the key and irregular expressions as 
values. Both in-house domain ontologies and mapping references should be improved, 
validated, maintained, and reused over time.  
3.3.5 Data transformation process 
Here, we describe a snapshot of the data transformation process. Typically, this process 
requires a set of leaf class attributes for a domain ontology, a mapping table that connects 
the leaf class data elements and the source data elements, a data structure transformation 
program, and a set of source data (Fig 3). At the end of this process, the source data 
structures and values are all transformed according to the concept descriptor classification 
in the domain ontology. The original source data attribute name is now released from the 
name domain (red boxes in Fig 3) of a data element and becomes a piece of value record 








Aribute name Instance  valuevalueLeaf  aribute
Match/Standardize



























Assemble new data elements
Remove the mapping media  - transformaon takes place 
Domain template
 
Fig. 3. A generalized data transformation processs using dynamically evolved domain 
ontology and mapping media. 
4. Results  
4.1 UNIFIN framework overview 
UNIFIN is implemented through the TraM and TraW projects. TraM runs on an Oracle 
database server and a TomCat web application server. TraW also runs on an Oracle 
database, but is operated in a secluded intranet because it processes patient PHI records (Fig 
4). TraM and TraW do not have software component dependencies, but are functionally 
interdependent in order to carry out the mission of personalized biomedical data 
integration. Fig 4 shows the UNIFIN architecture with notations about its basic technical 
components. 
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Fig. 4. UNIFIN overview: Dashed lines for the panel on the left indicate the workflow that 
does not route through TraW but is still a part of UINFIN. Red lines indicate secured file 
transmission protocols. Areas within the red boxes indicate HIPAA compliant 
computational environments. The right side panel of TraW indicates other data integration 
destinations other than TraM. 
Whereas the web application interface of TraM provides user friendly data account 
management, curation, query and retrieving functions for biomedical researchers, TraW is 
meant for informaticians, who are assumed to have both domain knowledge and 
computation skills.  
4.2 A use case of TraM data integration 
We use the example of medical survey data, one of the least standardized and structured 
datasets in biomedical studies, to illustrate how domain ontology can play an important role 
in TraM.  It is not uncommon to see the same survey concept (i.e., question) worded 
differently in several questionnaires and to have the data value (i.e., answer) to the same 
question expressed in a variety of ways. The number of survey questions per survey subject 
varies from fewer than ten to hundreds. Survey subject matter changes as research interest 
shifts and no one can really be certain as to whether a new question will emerge and what 
the question will look like. Therefore,  although medical survey data is commonly required 
for a translational research plan (refer to the example in 2.1), there is little data integration 
support for this kind of data and some suggest that survey data does not belong in a clinical 
conceptual data model (Brazhnik and Jones 2007).  
To solve this problem, we proposed an ontology structure to manage the concepts in the 
questionnaires. Within the DO, the questions are treated as data in the leaf class of the 
questionnaire and organized under different categories and branches. Each question, such 
as what, when, how, and why, has a set of properties that define an answer. These 
properties include data type (number or text), unit of measure (cup/day, pack/day, ug/ml), 
and predefined answer options (Fig 5A). 
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Fig. 5. Domain ontology and data integration: A) Leaf class attributes of the questionnaire; 
B) Instance data described by domain ontology. Both A and B are screenshots from the TraM 
curator interface (explained in 4.4). The left hand panel of screen B shows hyperlinks to the 
other domains that can also be associated with the individual (TR_0001894). The data shown 
is courtesy from the account of centre for clinical cancer genetics 
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Since a new question and its properties are treated as a new record (a new row in the leaf 
class table), the overall database structure stays the same. Since the possible answers in the 
survey are pre-defined with controlled vocabulary, the answers will be recorded in a 
relationship between the person entity and the question item entity. The survey results are 
also instantly and seamlessly integrated with the other domain data (Fig 5B). This 
underlying mechanism is meant to allow for the new question to play a double role: first, as 
a record (value) in the questionnaire ontology and second, as a question concept to recruit 
the survey result. In this way, the TraM system gains enormous flexibility in recruiting new 
concepts and is able to annotate data with controlled vocabularies.  
4.3 A life-cycle of TraW process 
Running a life-cycle of TraW takes four steps:  1) extract atomic data elements from various 
source data files; 2) unify (transform) data structure at the atomic data element level and 
mashup data into proper intermediate domain templates; 3) standardize (translate) and 
validate data values upon mixed data elements on the domain templates; 4) load and 
restructure data from domain templates into a target schema and complete integration.  
We have yet to gain much experience in extracting data directly from sources since most of 
the medical data sources that we work with deny programmatic data access. The source 
data files we obtained are in table or XML formats delivered through a secured file transport 
process (SFTP).  
The person(s) who operates TraW is also responsible for customizing and maintaining the 
essential constituent components. This responsibility includes editing domain templates, 
maintaining data mapping references and modifying programs in the toolkit. As a high-
throughput computation process, TraW may drop a list of disqualified data at each step and 
keep moving forward. Disqualified data will be sent to a curator for further validation. 
Recovered data may rejoin the workflow after verification to be processed with other data 
(Fig 6). Unified and standardized data on the domain templates (in the S-forms, refer section 
3.3.2) are in a mashup status but not integrated. Integration is realized through the loading 
procedure which resumes ER structures and constraints in the destination. Since domain 
templates provide a standardized and stabilized data inventory, loading procedures can be 































Fig. 6. Semi-automated TraW process  
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4.4 Information delivery 
Evaluation of the success of the UNIFIN approach is assessed by its final products: 
personalized biomedical data and the applications that deliver these data. The quality of 
TraM data reflects the integration capacity of the TraM schema and efficiency of the TraW 
process and is measured by data uniformity, cleanness and integrity.  A researcher who 
demands individualized cross-domain data (as described in the example in 2.1) should be 
able to query through the TraM application interface to obtain satisfactory information.   
Specifically, quality data should have the following features: 1) the same domain data 
should have consistent data elements (e.g., domain CDEs) and data descriptors; 2) all 
specimens, which are the linkage between clinical and basic science records, should be bar-
coded and annotated with at minimum, the person’s demographic information; 3) various 
domain data derived from the same person should be interlinked regardless of their 
disparate sources; 4) redundancies and discrepancies in the data are rigorously controlled at 
all hierarchical levels of schema and domains. Fig 7 displays some of these features of the 
TraM data in a breast cancer translational research account. 
 
 
Fig. 7. An example of the TraM data (screenshot on the regular user interface): In this 
particular query, the user used filters for three negative breast cancer biomarkers (noted as 
probe names), while other domain data are also displayed on the screen, including specimen 
samples. Each data field provides hyperlinks to allow for navigation to more detailed 
domain records. Important time stamps, e.g., the dates of diagnosis, surgery, and 
medication, are also shown. The export function allows users to retrieve normalized data in 
any domain, including detailed domain data that are not shown on this screen. The data 
shown is courtesy of a breast cancer translational research account.  
On average, when data are collected from more than 10 independent sources (batch data 
processing usually contains data from 10-30 disparate sources), around 50% of the distinct 
individual counts from these sources will be eliminated after data descriptor standardization 
and error correction, which means that about 50% of the person counts in the raw data are 
redundant because of heterogeneous descriptions and errors generated by humans in 
disparate sources. Furthermore, 50%-60% of source data elements do not match the target 
schema or among themselves because of semantic heterogeneity (detailed in section 3.3), 
which means that these elements need to go through a data structure transformation in order 
to retain the data carried by these elements. Although these simple statistics only reflect the 
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situation of the ETL executed between our data sources and our particular target schema, it 
delivers a piece of important information: complicated data transformation and curation are 
required to achieve personalized biomedical data integrity in the real world. 
For a biomedical data source that contains detailed patient data with records of time stamps, 
even de-identified, the data source usually is not freely accessible because of HIPAA 
concerns. Therefore, the application of the TraM data is quite different from a conventional 
biological data source in the way how data is accessed. First, the TraM data that contains 
healthcare administrative dates can only be viewed through project accounts. Each account 
usually contains at least one institutional research board (IRB) protocol (Fig 7). Researchers 
need to be approved by the same IRB protocol that patients have consented to in order to 
view the data within the account.  
Under each project account, TraM offers four kinds of user interfaces and each allows a 
specified user role to access data with a uniquely defined privilege. 1) The role of account 
administrator has the highest privilege within an account and the person manages users 
within the account by assigning them different roles. 2) The role of curator has write 
privileges so the person can edit data even after the data have been loaded into the TraM 
system (Fig 5). 3) The role of power uses, usually a physician, under IRB approval, has 
privileges to view the patient’s medical record number which is considered as PHI, but has 
no right to edit data. Finally 4) the role of regular user can view all de-identified TraM data 
(Fig 7). Although unlimited accounts are allowed to access the TraM data based on IRB 
protocols, there is only one copy of integrated data in the database. If the IRB protocols that 
a patient has consented to happen to be in different accounts, the patient’s records will be 
shared by these accounts without duplicate records in database.  
5. Discussions 
Personalized biomedical data integration is a complicated and perpetual challenge in 
biomedical informatics. Simply utilizing a single method, technology, or system architecture 
may not solve all of the problems associated with the process. In comparison to the other 
software products available in this line of work, the focus of UNIFIN is on data processing 
for integration, a goal that the system has achieved utilizing current real-world data. The 
architecture of UNIFIN is supported by a highly abstracted data modelling strategy which 
provides a solid foundation to be modified, extended, and improved for future and 
presumably improved source data environments without altering its backbone structure. 
Issues related to UNIFIN are the following: 
Ad hoc versus sustainable solutions: Personalized biomedical data integration is on the frontier 
of scientific challenges on a day-to-day basis. Rapidly evolving research has forced many to 
adopt ad hoc data capture solutions to keep the records. These solutions usually capture 
data in as-is formats and the data, along with its descriptors, are not synthesized with 
concept abstraction, semantic normalization and vocabulary standardization. Some ad hoc 
approaches are unavoidable, especially when users who create ad hoc data are not computer 
professionals. However, we believe that the ad hoc solutions should be limited to raw data 
capture but not be promoted for multiple source data integration or integrated data 
management. Considering the cost, scope, and endeavour of a warehousing project, making 
an effort up front in the design stage to separate data concepts (variable carriers) from data 
values (instance data) will be rewarded with long term software architecture stability and 
function flexibility. A software product produced with such planning should be suitable to 
ad-hoc events and sustainable in a constantly evolving data source environment. Here, 
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sustainability does not mean that software is static and does not need to be modified. 
Instead, it means that if required, software can be modified at minimal cost to gain a 
significant improvement in capacity.  
Reuse and impact of human efforts: TraW is a workflow that requires human-intervention. The 
products of human intervention are data mapping references and domain ontologies. After 
about three years of effort, we have reduced the time needed for a life-cycle of data processing 
of the same scope of data from several months to a few weeks while gaining much improved 
quality consistency in the final product. Yet, one of the major reasons for us not able to 
further  significantly reduce the ETL time at present is semantic heterogeneity of source data 
and high modification frequency of data sources (minimal 3 times a year in some major data 
sources). These changes often require human cognitive attention to validate data matching, 
mapping, and transformation processes. In some cases (e.g., source data elements designed 
with implied or multiple overloaded meanings) off-line human research is required to form a 
data processing solution before proceeding. Therefore, it is important to design and maintain 
these mapping references to make the human-intensive products computable, so that they can 
be reused in data processing with a high-throughput manner. When these mapping references 
become more sophisticated, improved automation should be possible. At the current stage, the 
need of human intervention reveals a major limitation of the UNIFIN approach: TraW needs to 
be operated by experts in biomedical informatics, which not only slows down a process that 
was intended to be streamlined, but also has the potential to produce data with uneven quality 
due to the uncertainty of human behaviour.  
Position and contribution of warehousing solution in a biomedical data space: If there is a spectrum 
for data integration strategies based on their product integrity, warehousing solution appears 
to fall at the top of the spectrum as the most integrated while mashup at a position of less 
integrated. However, the two can be successfully interlinked when individualized studies 
need to be transformed into population studies, e.g., medical census. UNIFIN-like approaches 
will potentially become conduits that allow for significant amounts of information mashup by 
providing standardized quality data. In order to form a harmonized ecosystem in the data-
space, warehouse data sources need to work towards using interchangeable domain 
ontologies and CDEs to process data and making these data available for interoperable 
sharing. If this does not occur, the sprawling warehouses, which usually collect regional 
biomedical data, may contribute to yet another layer of data heterogeneity.  
6. Conclusion 
We have created and tested a warehousing framework consisting of a unique database 
conceptual model and a systematically adjusted and enhanced ETL workflow for 
personalized biomedical data integration. The result is a real-world tested solution that is 
capable of consistently and efficiently unifying data from multiple sources for integration 
and delivering consumable information for use by translational researchers. The UNIFIN is 
a work-in-progress in the field that demands new knowledge and innovative solutions to 
this line of work.   
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